Abstract
Coronary heart disease (CHD) is the leading cause of death in women. Epidemiologic, mechanistic, and animal-model studies have produced convincing evidence that hormone replacement therapy (HRT) could substantially decrease rates of CHD in women. However, several randomized clinical trials of HRT in women with CHD have been unable to confirm the earlier suggestions of benefit, and there has even been a suggestion of increased CHD risk. This article will review the findings to date of these long-term randomized clinical trials of HRT for prevention or treatment of CHD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
